Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy

    Despite the success of immune checkpoint inhibitors (ICIs) in treating solid tumors, lots of patients remain unresponsive to this therapy. Microwave ablation (MWA) stimulates systemic adaptive immunity against...

    Shaoxian Wu, Hongwei Jiang, Zhang Fang, You Wu in Cancer Immunology, Immunotherapy (2024)

  2. Article

    Open Access

    Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy

    The multifaceted chemo-immune resistance is the principal barrier to achieving cure in cancer patients. Identifying a target that is critically involved in chemo-immune-resistance represents an attractive stra...

    Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang in Nature Communications (2024)

  3. No Access

    Article

    Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy

    Activation of scramblases is one of the mechanisms that regulates the exposure of phosphatidylserine to the cell surface, a process that plays an important role in tumour immunosuppression. Here we show that c...

    Yuang Chen, Yixian Huang, Qinzhe Li, Zhangyi Luo, Ziqian Zhang in Nature Nanotechnology (2023)

  4. Article

    Open Access

    Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways

    Oncolytic viruses (OVs) represent a new class of multi-modal immunotherapies for cancer, with OV-elicited antitumor immunity being key to their overall therapeutic efficacy. Currently, the clinical effectivene...

    Zhi Zhu, A. J. Robert McGray, Weijian Jiang, Binfeng Lu, Pawel Kalinski in Molecular Cancer (2022)

  5. Article

    Open Access

    IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity

    In this study, we aimed to apply the cytokine IL-36γ to cancer immunotherapy by constructing new oncolytic vaccinia viruses (OV) expressing interleukin-36γ (IL-36γ-OVs), leveraging unique synergism between OV and...

    Min Yang, Esther Giehl, Chao Feng, Mathilde Feist in Cancer Immunology, Immunotherapy (2021)

  6. Article

    Open Access

    Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions

    Gastric cancer is one of the leading causes of cancer-related death due to late diagnosis with high metastatic frequency. In this study, the impact of tumor secreted exosomes on immune function in the tumor en...

    Juan Liu, Shaoxian Wu, **ao Zheng, Panpan Zheng, Yuanyuan Fu in Scientific Reports (2020)

  7. Article

    Open Access

    B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2

    Accumulating evidence suggests that aerobic glycolysis is important for colorectal cancer (CRC) development. However, the underlying mechanisms have yet to be elucidated. B7-H3, an immunoregulatory protein, is...

    Tongguo Shi, Yanchao Ma, Lei Cao, Shenghua Zhan, Yunyun Xu in Cell Death & Disease (2019)

  8. No Access

    Article

    Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth

    Post-translational modification of chemokines mediated by the dipeptidyl peptidase DPP4 (CD26) has been shown to negatively regulate lymphocyte trafficking, and its inhibition enhances T cell migration and tum...

    Clémence Hollande, Jeremy Boussier, James Ziai, Tamaki Nozawa in Nature Immunology (2019)

  9. Article

    Open Access

    Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics

    Cancer vaccines and oncolytic immunotherapy are promising treatment strategies with potential to provide greater clinical benefit to patients with advanced-stage cancer. In particular, recombinant vaccinia vir...

    Zong Sheng Guo, Binfeng Lu, Zongbi Guo, Esther Giehl in Journal for ImmunoTherapy of Cancer (2019)

  10. No Access

    Article

    Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade

    Immunotherapy strategies have been emerging as powerful weapons against cancer. Early clinical trials reveal that overall response to immunotherapy is low in breast cancer patients, suggesting that effective s...

    Ye Qin, Shauna N. Vasilatos, Lin Chen, Hao Wu, Zhishen Cao, Yumei Fu, Min Huang in Oncogene (2019)

  11. Article

    Open Access

    High mRNA expression level of IL-6R was associated with better prognosis for patients with ovarian cancer: a pooled meta-analysis

    Interleukin-6 acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine. IL-6/IL-6R signaling pathway, in particular, has been proposed to be a pivotal cytokine promoting ovarian cancer progres...

    Qu Chen, Bin Xu, Lei Lan, Da Yang, Min Yang, **gting Jiang in Scientific Reports (2017)

  12. No Access

    Article

    Interleukin-33 Expression does not Correlate with Survival of Gastric Cancer Patients

    The aim of the study was to investigate IL-33 expression in gastric cancer (GC) and its association with the clinical characteristics and the prognosis. IL-33 protein in tumor and corresponding adjacent tissue...

    Wenwei Hu, **aodong Li, Qing Li, Yan Tan, Bin Xu in Pathology & Oncology Research (2017)

  13. Article

    Open Access

    Elastocaloric effect and superelastic stability in Ni–Mn–In–Co polycrystalline Heusler alloys: hysteresis and strain-rate effects

    Controlling material hysteresis and working frequency variability are fundamentally important for refrigeration cycle efficiency and power density in solid-state cooling systems. For elastocaloric cooling, und...

    Binfeng Lu, Jian Liu in Scientific Reports (2017)

  14. Article

    Open Access

    An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy

    Immunochemotherapy combines a chemotherapeutic agent with an immune-modulating agent and represents an attractive approach to improve cancer therapy. However, the success of immunochemotherapy is hampered by t...

    Yichao Chen, Rui **a, Yixian Huang, Wenchen Zhao, Jiang Li in Nature Communications (2016)

  15. No Access

    Article

    Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy

    Interleukin-33 (IL-33) is a member of the IL-1 gene family and mainly expressed in the nucleus of tissue lining cells, stromal cells, and activated myeloid cells. IL-33 is considered a damage-associated molecu...

    Binfeng Lu, Min Yang, Qingqing Wang in Journal of Molecular Medicine (2016)

  16. No Access

    Article

    Mechanocaloric materials for solid-state cooling

    This article reviews the up-to-date progress in mechanocaloric effect and materials near ambient temperature. For elastocaloric materials, we focus on directly measured temperature change and its entropy origi...

    Binfeng Lu, Jian Liu in Science Bulletin (2015)

  17. Article

    Open Access

    Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors

    CIK cells therapy has been evaluated as an adoptive cell immunotherapy for cancer patients, but there still have not been any standardized systems for evaluating the antitumor efficacy yet. The WHO and RECIST ...

    **ao-Dong Li, Mei Ji, **ao Zheng, Zhong-Hua Ning in Journal of Translational Medicine (2014)

  18. Article

    Open Access

    Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China

    α-Fetoprotein-producing gastric cancer (AFPGC) is a rare type of gastric cancer. The largest population of patients with AFPGC is found in China. In the present study, a total of 4,779 GC patients, including 3...

    **ao-Dong Li, Chang-** Wu, Mei Ji, Jun Wu in World Journal of Surgical Oncology (2013)

  19. Article

    Open Access

    Cytokine-induced killer cells promote antitumor immunity

    The number of immune cells, especially dendritic cells and cytotoxic tumor infiltrating lymphocytes (TIL), particularly Th1 cells, CD8 T cells, and NK cells is associated with increased survival of cancer pati...

    **gting Jiang, Chang** Wu, Binfeng Lu in Journal of Translational Medicine (2013)

  20. Article

    Open Access

    CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

    Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). In the murine experimental autoimmune encephalomyelitis (EAE) model of MS, T regulatory (Treg) cell therapy has proved to b...

    Moa Fransson, Elena Piras, Joachim Burman, Berith Nilsson in Journal of Neuroinflammation (2012)

previous disabled Page of 2